Daylight Solutions Inc., a San Diego-based manufacturer of molecular detection and imaging solutions in the mid-infrared, announced delivery of the world’s first commercially available laser-based infrared microscopy platform.
The company’s advanced microscope was delivered to Dr. Rebekah Drezek’s Optical Molecular Imaging and Nanobiotechnology Laboratory at Rice University in Houston. The system initially will be used to conduct research into laser-based infrared microscopy for the optical diagnosis of breast cancer.
The microscope, marketed under the brand name Spero, opens up a new world of research possibilities with chemical imaging and analysis on a real-time basis. Powered by Daylight’s Quantum Cascade Laser technology, Spero offers a combination of visibility, results in “live mode,” and a small resource footprint to easily fit into any lab or clinical setting. The system's capabilities are further augmented by automated computational algorithms that enable identification and segmentation of complex chemical signatures. Applications for Spero range from label-free tissue and cell diagnostics in life sciences to materials analysis in industrial markets.